Home
About
Overview
Sharing Data
ORCID
Help
History (65)
Ether
The mission and strategic goals of AADE are reaffirmed as we move into 2010.
Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.
The evolution of our thinking about microRNAs.
Imatinib mesylate treatment of nephrogenic systemic fibrosis.
See All 65 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Imatinib mesylate treatment of nephrogenic systemic fibrosis.
Kay J, High WA. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 2008 Aug; 58(8):2543-8.
View in:
PubMed
subject areas
Aged
Benzamides
Fibrosis
Humans
Imatinib Mesylate
Kidney Diseases
Knee Joint
Male
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Scleroderma, Systemic
Skin
Treatment Outcome
authors with profiles
Jonathan Kay MD